Related Videos

  1. Dividend Appeal Lacking in Abbott Split-Up

    Fri, 9 Nov 2012

    The newly public AbbVie's dividend will be too concentrated to a single drug, while the payout from the remaining Abbott entity won't be as generous as in years past, according to Morningstar's Josh Peters.

Content Partners